Seven things to know:
1. Net sales grew 10.7% increase year over year in the first quarter, according to a news release.
2. Orthopedic sales were $2.5 billion for the fourth quarter, a 10.8% increase year over year.
3. MedSurg and neurotechnology sales were $3.9 billion during the fourth quarter, a 10.6% increase year over year.
4. Stryker’s fourth quarter net earnings decreased 52.2% year over year with $500 million.
5. Stryker expects 2025 revenue to grow 8% to 9%.
6. Full year sales for 2024 were $22.6 billion, an increase of 10.2% compared to 2023. Full year net earnings of $3 billion represents a 5.4% decrease from 2023.
7. Stryker is planning to sell its U.S. spine implants business to an investment firm, the company said Jan. 28. The move also includes a binding offer to sell off Stryker’s spine implants business in France.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
